Addressing the Burden of Psoriatic Arthritis: Moving Beyond the Joint

To participate in this activity, please:

Philip J. Mease, MD, and Alexis R. Ogdie-Beatty, MD, review the pathogenesis and a wide spectrum of clinical features, manifestations, and comorbidities of psoriatic arthritis; talk about classification criteria for PsA and different patient-reported and provider-assessed outcome measures; and discuss treatment recommendations and strategies, as well as various types of current and emerging therapies. Finally, they highlight some of the key issues and challenges of the management of PsA through reviewing patient case studies.

Course Credit:

2.50 AANP Contact Hours
2.50 AMA PRA Category 1 CreditsTM


Opens: 2020-01-31
Closes: 2021-01-30

Target Audience:

This activity was developed for rheumatologists, dermatologists, primary care physicians, nurse practitioners, physician assistants and other health care providers who manage patients with psoriatic arthritis (PsA).

This activity is supported by an independent educational grant from Pfizer.
  • Alexis Ogdie-Beatty, MD, MSCE

    Associate Professor of Medicine at the Hospital of the University of Pennsylvania
    Director, Penn Psoriatic Arthritis Clinic
    University of Pennsylvania
    Philadelphia, Pennsylvania           

  • Philip J. Mease, MD
    Seattle Rheumatology Associates
    Swedish Medical Center
    University of Washington
    Seattle, Washington


This course has no downloads at this time.

Learning Objectives

  • Utilize validated tools to assess psoriatic arthritis (PsA) disease burden and response to treatment
  • Summarize the clinical pharmacology, including mechanism of action, as well as safety and efficacy, of evidence-based medications for PsA
  • Utilize a treat-to-target approach with individualized evidence-based therapy to reduce symptom burden and, when possible, achieve disease remission/low disease activity
  • Identify and implement treatment of comorbidities of PsA in collaboration with the primary care provider

Faculty Disclosures

Alexis Ogdie-Beatty, MD, MSCE

Consultant - AbbVie, Amgen, BMS, Celgene, Corrona, Lilly, Novartis, Pfizer, UCB

Philip J. Mease, MD

No relationships to disclose.

Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.
This program is designated for up to 2.50 contact hours. Program ID# 5803-EM.

Additional Content Planners

Emir Hadzick, PhD (Medical Writer)
No significant relationships to disclose.

Heather M. Jimenez, FNP-C (Nurse Planner)
No significant relationships to disclose.

Kam A. Newman, MD (Peer Reviewer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

All staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.